Sr. Product Development Scientist

- Drug Formulation Specialist

Position summary

We are seeking a Senior Product Development Scientist with strong expertise in drug formulation to join our R&D team. You will lead and drive formulation and product development to advance innovative oral drug products from preclinical and clinical development. You will combine hands-on laboratory work with scientific leadership, working cross-functionally, and acting as a key scientific interface toward external partners. We are specifically looking for a scientist with strong hands-on experience in oral solid dosage (OSD) product development, including prototype tablet and capsule development, and preferably experience with amorphous drug formulations, such as amorphous solid dispersions (ASDs) or other enabling formulation technologies. This is an excellent opportunity for a PhD-level scientist who thrives in a dynamic, collaborative, and impact-driven environment..

Key responsibilities

Design and execute formulation strategies using Formulite^®to enhance solubility, bioavailability, and stability
Lead and contribute to development programs across internal pipeline and partner projects
Act as a scientific expert toward external customers and development partnerships
Generate, interpret, and present high-quality data to internal and external stakeholders
Develop prototype oral solid dosage forms, including tablets and capsules
Optimize formulations and manufacturing processes for oral drug products
Plan and evaluate optimized formulations, in vitro dissolution studies, including development of IVIVC models
Contribute to CMC documentation, , and development reports
Support intellectual property generation, including invention disclosures and patent strategy
Represent Disruptive Pharma at scientific conferences, partner meetings, and external engagements

Qualifications

Strong collaborative mindset and communication skills
PhD in pharmaceutics, materials science, chemistry, or related field
3–5+ years of industrial (preferred) or postdoctoral (optional) experience in pharmaceutical product development
Strong experience in oral drug formulation, preferably including amorphous solid dispersions or enabling technologies
Demonstrated hands-on experience in oral solid dosage (OSD) formulation development, including tablet and/or capsule development
Experience with material characterization techniques is highly desirable
Proven ability to work in cross-functional teams and/or in customer-facing scientific roles
Experience contributing to IP generation or patent strategy is an advantage
Strong scientific communication skills, both written and oral
Full working proficiency in English and Swedish

Why join us?

At Disruptive Pharma, you will join a highly skilled and entrepreneurial team working at the forefront of material science and pharmaceutical innovation.
You will have the opportunity to:

Work hands-on with a unique and proprietary technology platform (MMC/Formulite^®
Play a key role in advancing partner programs, development offerings and internal pipeline
Combine deep science with real-world impact, helping bring better medicines to patients
Engage in external collaborations, conferences, and business-facing activities
Contribute directly to the growth and success of a cutting-edge platform company

Location: Uppsala-Stockholm, Sweden
Department: R&D
Reports to: Director R&D

Apply by August 14, 2026
To apply, please send your CV and a brief cover letter to Sofia Mogensen, Director R&D, at sofia.mogensen@disruptivepharma.com.
For questions about the position, please contact Sofia at sofia.mogensen@disruptivepharma.com.

About Disruptive Pharma
Disruptive Pharma is a Swedish pharmaceutical technology company developing Formulite^® a patented and clinically evaluated bioavailability platform designed to improve the performance of oral drug products.
Formulite^®is based on mesoporous magnesium carbonate (MMC) and stabilizes poorly soluble drug compounds in an amorphous state. The platform addresses challenges related to poor solubility, limited oral bioavailability and manufacturability in oral formulation development.
We partner with biotech and pharmaceutical companies through tailored feasibility and development programs, applying our technology to challenging compounds from early screening through formulation development and scale-up.